Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia
β Scribed by Laura Cudillo; Andrea Tendas; Alessandra Picardi; Teresa Dentamaro; Maria Ilaria Del Principe; Sergio Amadori; Paolo de Fabritiis
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 149 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Pulmonary aspergillosis and other invasive fungal infections (IFIs) commonly complicate the management of patients with acute leukemia. Standard amphotericinβbased therapies may be ineffective for many patients and the available salvage agents (itraconazole and caspofungi
## Abstract A 3 1/2 year old girl with cystic fibrosis who underwent successful treatment for acute lymphoblastic leukemia remains in complete remission 36 months after diagnosis. We also report high clearance rates of three antineoplastic agents in this patient. Drug doses were adjusted to achieve
## Abstract Herein we report the successful treatment of invasive aspergillosis with the liposomal amphotericin B (AMB) formulation, Amphotericin B Lipid Complex (ABLCβ’). This investigational compound was employed in a 50βyearβold patient with acute myelomonocytic leukemia complicated by prolonged,